Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients
Dariusz Koziorowski, Ryszard Tomasiuk, Stanisław Szlufik, et al.
Cytokine (2012) Vol. 60, Iss. 3, pp. 762-766
Closed Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Madelyn C. Houser, Malú G. Tansey
npj Parkinson s Disease (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 475
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease
Xiao‐Yan Qin, Shuping Zhang, Chang Cao, et al.
JAMA Neurology (2016) Vol. 73, Iss. 11, pp. 1316-1316
Closed Access | Times Cited: 445
Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis
Vittorio Calabrese, Aurelia Santoro, Daniela Monti, et al.
Free Radical Biology and Medicine (2017) Vol. 115, pp. 80-91
Open Access | Times Cited: 314
The Role of Innate and Adaptive Immunity in Parkinson's Disease
George T. Kannarkat, Jeremy M. Boss, Malú G. Tansey
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 4, pp. 493-514
Open Access | Times Cited: 298
Mitophagy: An Emerging Role in Aging and Age-Associated Diseases
Guo Chen, Guido Kroemer, Oliver Kepp
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 289
Mesenchymal Stem Cells for Neurological Disorders
A Andrzejewska, Sylwia Dabrowska, Barbara Łukomska, et al.
Advanced Science (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 271
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Valerie Joers, Malú G. Tansey, Giovanna Mulas, et al.
Progress in Neurobiology (2016) Vol. 155, pp. 57-75
Open Access | Times Cited: 253
Neuroimmunological Processes in Parkinson's Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
Vanesa Sánchez-Guajardo, Christopher J. Barnum, Malú G. Tansey, et al.
ASN NEURO (2013) Vol. 5, Iss. 2, pp. AN20120066-AN20120066
Open Access | Times Cited: 221
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
Erdinç Dursun, Duygu Gezen‐Ak, Haşmet Hanağası, et al.
Journal of Neuroimmunology (2015) Vol. 283, pp. 50-57
Closed Access | Times Cited: 218
Inflammation is genetically implicated in Parkinson’s disease
Nicolas Dzamko, Carolyn L. Geczy, Glenda M. Halliday
Neuroscience (2014) Vol. 302, pp. 89-102
Closed Access | Times Cited: 209
Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies
Natália Pessoa Rocha, Aline Silva de Miranda, Antônio Lúcio Teixeira
BioMed Research International (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 191
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Zheng Fan, Yuting Pan, Zhiyuan Zhang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 169
Inflammation, Infectious Triggers, and Parkinson's Disease
Elisa Caggiu, Giannina Arru, Sepideh Hosseini, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 168
Biomarker of Neuroinflammation in Parkinson’s Disease
Tsai-Wei Liu, Chiung‐Mei Chen, Kuo‐Hsuan Chang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4148-4148
Open Access | Times Cited: 126
Parkinson's Disease: A Multisystem Disorder
Helena Nunes Costa, A. Raquel Esteves, Nuno Empadinhas, et al.
Neuroscience Bulletin (2022) Vol. 39, Iss. 1, pp. 113-124
Closed Access | Times Cited: 83
Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapy
Nathan Watson, Bo Ding, Xiaoxia Zhu, et al.
Ageing Research Reviews (2017) Vol. 40, pp. 142-148
Open Access | Times Cited: 163
Evidence of Inflammatory System Involvement in Parkinson’s Disease
Yinxia Chao, Siew Cheng Wong, Eng King Tan
BioMed Research International (2014) Vol. 2014, pp. 1-9
Open Access | Times Cited: 140
TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells
Paresh Prajapati, Lakshmi Sripada, Kritarth Singh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 3, pp. 451-461
Closed Access | Times Cited: 110
Mapping inflammation onto mood: Inflammatory mediators of anhedonia
Walter Swardfager, Joshua D. Rosenblat, Meriem Benlamri, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 64, pp. 148-166
Closed Access | Times Cited: 110
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
Irene López González, Paula Garcia‐Esparcia, Franc Llorens, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 2, pp. 206-206
Open Access | Times Cited: 94
(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
Tingting Zhou, Mengru Zhu, Zhanhua Liang
Molecular Medicine Reports (2018)
Open Access | Times Cited: 90
Peripheral blood inflammatory markers in early Parkinson’s disease
Ryul Kim, Han‐Joon Kim, Aryun Kim, et al.
Journal of Clinical Neuroscience (2018) Vol. 58, pp. 30-33
Closed Access | Times Cited: 86
An overview of sleep and circadian dysfunction in Parkinson's disease
Susanna Mantovani, Simon S. Smith, Richard D. Gordon, et al.
Journal of Sleep Research (2018) Vol. 27, Iss. 3
Open Access | Times Cited: 85
Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease
Dimitri Koutzoumis, Macarena Vergara, José A. Pino, et al.
Experimental Neurology (2019) Vol. 325, pp. 113159-113159
Closed Access | Times Cited: 84
Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved
Diana Denisse Álvarez‐Luquín, Asiel Arce-Sillas, Jaquelín Leyva-Hernández, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top